My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 231

    1.

    Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.

    Vadhan-Raj S, Verschraegen CF, Bueso-Ramos C, Broxmeyer HE, Kudelkà AP, Freedman RS, Edwards CL, Gershenson D, Jones D, Ashby M, Kavanagh JJ.

    Ann Intern Med. 2000 Mar 7;132(5):364-8.PMID: 10691586 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor]

    Bai CM, Xu GX, Zhao YQ, Han SM, Shan YD.

    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Aug;26(4):437-41. Chinese. PMID: 15379272 [PubMed - indexed for MEDLINE]Related articles

    3.

    [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia]

    Bai CM, Zou XY, Zhao YQ, Han SM, Shan YD; Thrombopoietin Clinical Trail Cooperation Group.

    Zhonghua Yi Xue Za Zhi. 2004 Mar 2;84(5):397-400. Chinese. PMID: 15061993 [PubMed - indexed for MEDLINE]Related articles

    4.

    Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia.

    Vadhan-Raj S.

    Semin Hematol. 2000 Apr;37(2 Suppl 4):28-34. Review.PMID: 10831286 [PubMed - indexed for MEDLINE]Related articles

    5.

    Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer.

    Vadhan-Raj S, Murray LJ, Bueso-Ramos C, Patel S, Reddy SP, Hoots WK, Johnston T, Papadopolous NE, Hittelman WN, Johnston DA, Yang TA, Paton VE, Cohen RL, Hellmann SD, Benjamin RS, Broxmeyer HE.

    Ann Intern Med. 1997 May 1;126(9):673-81.PMID: 9139552 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Recombinant human thrombopoietin in myelosuppressive chemotherapy.

    Vadhan-Raj S.

    Oncology (Williston Park). 2001 Jul;15(7 Suppl 8):35-8.PMID: 11497230 [PubMed - indexed for MEDLINE]Related articles

    7.

    Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.

    Vadhan-Raj S, Kavanagh JJ, Freedman RS, Folloder J, Currie LM, Bueso-Ramos C, Verschraegen CF, Narvios AB, Connor J, Hoots WK, Broemeling LD, Lichtiger B.

    Lancet. 2002 Jun 22;359(9324):2145-52.PMID: 12090979 [PubMed - indexed for MEDLINE]Related articles

    8.

    Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia.

    Vadhan-Raj S, Patel S, Bueso-Ramos C, Folloder J, Papadopolous N, Burgess A, Broemeling LD, Broxmeyer HE, Benjamin RS.

    J Clin Oncol. 2003 Aug 15;21(16):3158-67.PMID: 12915607 [PubMed - indexed for MEDLINE]Related articles

    9.

    The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation.

    Schuster MW, Beveridge R, Frei-Lahr D, Abboud CN, Cruickshank S, Macri M, Menchaca D, Holden J, Waller EK.

    Exp Hematol. 2002 Sep;30(9):1044-50.PMID: 12225796 [PubMed - indexed for MEDLINE]Related articles

    10.

    Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer.

    Basser RL, Rasko JE, Clarke K, Cebon J, Green MD, Grigg AP, Zalcberg J, Cohen B, O'Byrne J, Menchaca DM, Fox RM, Begley CG.

    Blood. 1997 May 1;89(9):3118-28. Erratum in: Blood 1997 Sep 15;90(6):2513. PMID: 9129014 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experience.

    Angiolillo AL, Davenport V, Bonilla MA, van de Ven C, Ayello J, Militano O, Miller LL, Krailo M, Reaman G, Cairo MS; Children's Oncology Group.

    Clin Cancer Res. 2005 Apr 1;11(7):2644-50.PMID: 15814645 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer.

    Fanucchi M, Glaspy J, Crawford J, Garst J, Figlin R, Sheridan W, Menchaca D, Tomita D, Ozer H, Harker L.

    N Engl J Med. 1997 Feb 6;336(6):404-9.PMID: 9010146 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Enhancement of platelet recovery after myelosuppressive chemotherapy by recombinant human megakaryocyte growth and development factor in patients with advanced cancer.

    Basser RL, Underhill C, Davis I, Green MD, Cebon J, Zalcberg J, MacMillan J, Cohen B, Marty J, Fox RM, Begley CG.

    J Clin Oncol. 2000 Aug;18(15):2852-61.PMID: 10920133 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of recombinant human thrombopoietin in nonhuman primates with chemotherapy-induced thrombocytopenia.

    Akahori H, Shibuya K, Obuchi M, Nishizawa Y, Tsuji A, Kabaya K, Kusaka M, Ohashi H, Tsumura H, Kato T, Miyazaki H.

    Br J Haematol. 1996 Sep;94(4):722-8.PMID: 8826901 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Phase II clinical trial on China manufactured recombinant human interleukin-11 derivative in the prevention and treatment of chemotherapy-induced thrombocytopenia]

    Wang XY, Feng FY, Song ST, Wang HQ, Zhang MH, Liu J, Liu XY, Xu LG, Zhang Y.

    Zhonghua Zhong Liu Za Zhi. 2005 Jun;27(6):373-6. Chinese. PMID: 16117903 [PubMed - indexed for MEDLINE]Related articles

    16.

    The haemopoietic effects of thrombopoietin administered post-myelosuppressive carboplatin therapy compared to either pre- and post- or pre-chemotherapy.

    van de Ven C, Fernandez GW, Herbst T, Knoppel A, Kulczyk ST, Cairo MS.

    Br J Haematol. 1998 Aug;102(3):775-82.PMID: 9722306 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effects of interleukin-1 alpha on carboplatin-induced thrombocytopenia in patients with recurrent ovarian cancer.

    Vadhan-Raj S, Kudelka AP, Garrison L, Gano J, Edwards CL, Freedman RS, Kavanagh JJ.

    J Clin Oncol. 1994 Apr;12(4):707-14.PMID: 8151314 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Effectiveness and safety of recombinant human interleukin-11 in the treatment of chemotherapy-induced thrombocytopenia]

    Lei W, Liang J, Chen WG, Ma XZ, Xu M, Du LL.

    Zhonghua Zhong Liu Za Zhi. 2006 Jul;28(7):542-4. Chinese. PMID: 17147124 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients]

    Xu YH, Chen ZW, Ye XY, Lu S.

    Zhonghua Zhong Liu Za Zhi. 2008 Sep;30(9):716-9. Chinese. PMID: 19173920 [PubMed - in process]Related articles

    20.

    Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study.

    Wolff SN, Herzig R, Lynch J, Ericson SG, Greer JP, Stein R, Goodman S, Benyunes MC, Ashby M, Jones DV Jr, Fay J.

    Bone Marrow Transplant. 2001 Feb;27(3):261-8.PMID: 11277173 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity